Literature DB >> 8167335

Regulation of the interleukin-3 (IL-3) receptor by IL-3 in the fetal liver-derived FL5.12 cell line.

P A Algate1, L S Steelman, M W Mayo, A Miyajima, J A McCubrey.   

Abstract

To determine the effects of a cytokine on cognate receptor expression in normal and neoplastic cells, the interleukin-3 receptor (IL-3R) complex was examined in the parental IL-3-dependent line FL5.12, which was isolated from fetal liver, and in autocrine- and v-abl-transformed derivative lines. IL-3 decreased the amount of the IL-3R alpha and beta chains detected on the cell surface of the parental IL-3-dependent cells. In contrast, high levels of IL-3R beta were constitutively detected on the autocrine-transformed lines in the absence and presence of exogenous IL-3. Only low levels of IL-3R beta were observed in the two v-abl-transformed derivative cell lines examined, which no longer required IL-3 for growth. The levels of the IL-3R alpha chain detected were similar in these transformed cells and were not regulated by IL-3. These results were substantiated further by RNA analysis, because IL-3 decreased the levels of IL-3R transcripts in the parental factor-dependent FL5.12 line. The pattern of IL-3R gene expression was opposite to that of other receptors or proto-oncogenes, because RNA transcripts for all other genes examined were induced by IL-3. We conclude that IL-3 tightly controls IL-3R expression in the IL-3-dependent FL5.12 cells, whereas steady-state mRNA levels were not altered in the two v-abl-transformed derivative cell lines examined in this study.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8167335

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  3 in total

1.  Evidence Suggesting That Discontinuous Dosing of ALK Kinase Inhibitors May Prolong Control of ALK+ Tumors.

Authors:  Amit Dipak Amin; Soumya S Rajan; Winnie S Liang; Praechompoo Pongtornpipat; Matthew J Groysman; Edgar O Tapia; Tara L Peters; Lori Cuyugan; Jonathan Adkins; Lisa M Rimsza; Yves A Lussier; Soham D Puvvada; Jonathan H Schatz
Journal:  Cancer Res       Date:  2015-05-27       Impact factor: 12.701

2.  The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor.

Authors:  Casey J Fox; Peter S Hammerman; Ryan M Cinalli; Stephen R Master; Lewis A Chodosh; Craig B Thompson
Journal:  Genes Dev       Date:  2003-07-17       Impact factor: 11.361

3.  TKI sensitivity patterns of novel kinase-domain mutations suggest therapeutic opportunities for patients with resistant ALK+ tumors.

Authors:  Amit Dipak Amin; Lingxiao Li; Soumya S Rajan; Vijay Gokhale; Matthew J Groysman; Praechompoo Pongtornpipat; Edgar O Tapia; Mengdie Wang; Jonathan H Schatz
Journal:  Oncotarget       Date:  2016-04-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.